Found 80 matching trials
Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy
PHASE1The study is an open label, non-randomized study designed to evaluate the d...
Location
Johns Hopkins University
Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MR
NABackground:
Currently, patients suspected of having prostate cancer underg...
Location
Princess Margaret Cancer Centre
18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy
PHASE2Background:
Identifying medium- and high-risk prostate cancer early may al...
Location
National Institutes of Health Clinical Center
Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan
PHASE4The purpose of this research study is to see how well an imaging test, call...
Location
Dana Farber Cancer Institute
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging
N/AQuantitative parameters obtained with dynamic whole body imaging using posi...
Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy
PHASE1Background:
Prostate cancer is the second leading cause of cancer death in...
Location
National Institutes of Health Clinical Center
PSMA PET/CT for Assessment of Recurrent Prostate Cancer
N/AProstate cancer (PC) is the third most common cause of cancer death in men....
Status
Active Not Recruiting
Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer.
PHASE1The objective of this study is to evaluate a radiolabeled urea-based small ...
Location
Johns Hopkins University
High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy
PHASE2This prospective trial aims to determine if enhanced prostate imaging using...
Location
Cedars-Sinai Medical Center
PSMA Therapy and Immunotherapy in Kidney Cancer
PHASE1This is a multi-center, single arm open label phase 1b/2 study of pembroliz...
Location
Multiple Locations